Nanomedicine Research Center Core (NRCC)
Nanomedicine Research Center Core (NRCC)
批准号:
7936169
负责人:
Shyam S Mohapatra
金额:
$66.45万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2013-06-30
关键词:
3-DimensionalAffectAreaArtsBasic ScienceBloodCellsClinicCollaborationsDiscipline of NursingDoctor of PhilosophyEngineeringEquipment and SuppliesFacultyFloridaFosteringFundingGoalsHeartHematological DiseaseHospitalsHuman ResourcesImmuneIndividualIndustryInterdisciplinary StudyKnowledgeLaboratoriesLifeLungLung diseasesMedicalMedicineMissionMolecularNanotechnologyOccupationsPositioning AttributePostdoctoral FellowPublic HealthQualifyingResearchResearch ProposalsResourcesRespiratory SystemScienceScientistStem cellsTechnologyTissue EngineeringTrainingTranslational ResearchTranslationsUniversitiesVirus DiseasesWagesWashingtonWorkcatalystcollegegraduate studentinnovationinstructormembermultidisciplinarynanonanomedicinetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal seeks support for new faculty recruitment to enhance research resources for the Nanomedicine Research Center (NRC) at the University of South Florida College of Medicine, whose mission is to serve as a catalyst for advancing the basic and translational aspects nanomedicine for Heart, Lung and Blood disorders. The NRC goals are to: (i) develop innovative and integrative nano- and cell-technologies, (ii) nurture and foster the transition of these advanced technologies from the laboratory to the clinic, (iii) foster university-industry and Florida-wide collaborations in nanomedicine, tissue engineering and cell technologies. The NRC members (about 18) include faculty from the colleges of Arts and Sciences, Engineering, Nursing Medicine and Public Health. The NRC seeks to create a multidisciplinary team of biologists, engineers, scientists and clinicians, working in a coordinated and focused effort, to develop integrated technology to accelerate the translation of molecular and cellular knowledge into nanotechnology applications for medical and cell technologies. The NRC is located at the College of Medicine and has satellite laboratories at the VA Hospital and Interdisciplinary Research Building. The Center currently has 6 core faculty and 12 adjunct faculty and several support staff, postdoctoral fellows and graduate students. The NRC has identified two areas of research for enhancement in order of importance: (i) immune cell-targeted therapeutics for lung diseases and (ii) stem cell-blood differentiation on 3-D nanomatrices. The NRC has identified Mary Markiewicz, PhD, Instructor at Washington Univ., St Louis as a potential candidate for tenure-track faculty at the NRC. The College of Medicine has made a commitment for this position with salary and start-up funding for support personnel, equipment and supplies following the completion of P-30 support. Dr. Mary Markiwicz's basic research on NKG2D as a potential immunomodulatory system for respiratory viral infections pursued at the NRC is excellent and is expected to enhance the NRC's nanomedicine application in basic and translational research. This support is not only expected to provide jobs for 4 highly trained individuals, but will significantly affect their lives and contributions to nanomedicine research.
This proposal seeks support for new faculty recruitment to enhance research resources for the Nanomedicine Research Center (NRC) at the University of South Florida College of Medicine, whose mission is to serve as a catalyst for advancing the basic and translational aspects nanomedicine for heart lung and blood disorders. This support will permit creation of four jobs to highly qualified individuals.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3727/096368910x536491
发表时间:
2011
期刊:
Cell transplantation
影响因子:
3.3
作者:
[Kumar A, Glaum M, El-Badri N, Mohapatra S, Haller E, Park S, Patrick L, Nattkemper L, Vo D, Cameron DF]
通讯作者:
Cameron DF
DOI:
10.3390/s130708490
发表时间:
2013-07-03
期刊:
Sensors (Basel, Switzerland)
影响因子:
--
作者:
[Huls NF, Phan MH, Kumar A, Mohapatra S, Mohapatra S, Mukherjee P, Srikanth H]
通讯作者:
Srikanth H
CD4(+) T cells suppress immune response to cancer: novel targets for antitumor efforts.
CD4(+) T 细胞抑制对癌症的免疫反应:抗肿瘤工作的新目标。
DOI:
10.1586/eci.12.29
发表时间:
2012
期刊:
Expert review of clinical immunology
影响因子:
4.4
作者:
[Nelson,Allison, Nair,Sajitha, Nagaraj,Srinivas]
通讯作者:
Nagaraj,Srinivas
DOI:
10.1016/j.bbrc.2008.07.051
发表时间:
2008-09-26
期刊:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子:
3.1
作者:
[Shirley, Shawna A., Montpeti, Alison J., Lockey, R. F., Mohapatra, Shyam S.]
通讯作者:
Mohapatra, Shyam S.
DOI:
10.1039/c2ra22293k
发表时间:
2013-02-28
期刊:
RSC advances
影响因子:
3.9
作者:
[Dixit S, Das M, Alwarappan S, Goicochea NL, Howell M, Mohapatra S, Mohapatra S]
通讯作者:
Mohapatra S
BLRD Merit Review Research Career Scientist Award
-
批准号:10594022
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Shyam S Mohapatra
-
依托单位:
Nanomicellar antiviral strategies for RSV infection
-
批准号:10516004
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Shyam S Mohapatra
-
依托单位:
BLRD Research Career Scientist Award Application
-
批准号:9898309
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Shyam S Mohapatra
-
依托单位:
BLRD Research Career Scientist Award Application
-
批准号:10265371
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Shyam S Mohapatra
-
依托单位:
Development of Nanotherapeutics for RSV-induced Lung Disease
-
批准号:8391625
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Shyam S Mohapatra
-
依托单位:
Development of Nanotherapeutics for RSV-induced Lung Disease
-
批准号:8598008
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Shyam S Mohapatra
-
依托单位:
Development of Nanotherapeutics for RSV-induced Lung Disease
-
批准号:8140565
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Shyam S Mohapatra
-
依托单位:
Conference: Advances in Translational Research in AIDS/HIV in INDIA
-
批准号:8071881
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2010
-
负责人:Shyam S Mohapatra
-
依托单位:
Nanomedicine Research Center Core (NRCC)
-
批准号:7856214
-
项目类别:
-
资助金额:$66.45万
-
财政年份:2009
-
负责人:Shyam S Mohapatra
-
依托单位:
Association between ANP and NPRA Gene Polymorphisms and Severity of Atopy and Ast
-
批准号:7472723
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2008
-
负责人:Shyam S Mohapatra
-
依托单位:
Association between ANP and NPRA Gene Polymorphisms and Severity of Atopy and Ast
-
批准号:7588784
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2008
-
负责人:Shyam S Mohapatra
-
依托单位:
Chlipoplex Nanoparticle Prophylactics for RSV Infection
-
批准号:6832584
-
项目类别:
-
资助金额:$15.79万
-
财政年份:2004
-
负责人:Shyam S Mohapatra
-
依托单位:
Chliposome IFN-gamma-pDNA Naoparticle Therapy for Asthma
-
批准号:6790906
-
项目类别:
-
资助金额:$11.0万
-
财政年份:2004
-
负责人:Shyam S Mohapatra
-
依托单位:
Chitosan IFNgamma-pDNA Nanosphere Therapy and Immunopathology of Allergic Asthma
-
批准号:6725650
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2003
-
负责人:Shyam S Mohapatra
-
依托单位:
Chitosan IFNgamma-pDNA Nanosphere Therapy and Immunopathology of Allergic Asthma
-
批准号:7119194
-
项目类别:
-
资助金额:$28.32万
-
财政年份:2003
-
负责人:Shyam S Mohapatra
-
依托单位:
Chitosan IFNgamma-pDNA Nanosphere Therapy and Immunopathology of Allergic Asthma
-
批准号:6803505
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2003
-
负责人:Shyam S Mohapatra
-
依托单位:
Chitosan IFNgamma-pDNA Nanosphere Therapy and Immunopathology of Allergic Asthma
-
批准号:6941671
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2003
-
负责人:Shyam S Mohapatra
-
依托单位:
海外基金